The box plots reflected that Bcl2 is highly upregulated in many tumors, including LUSC, BC, KIRC, LGG, THCA, HNSC, SARC, LUAD, and UCEC (Fig. 1). The highest expression of Bcl2 among these cancers was seen in breast cancer patients. This evidence concerns the gene BCL2 and breast cancer.